logo
ProjectCompleted

Sansure Biotech

Sector: Water Supply and Storage • Location: China

Source: International Finance Corporation (IFC)

 Sansure Biotech Inc. (“Sansure Biotech” or the “Company”) is an in vitro diagnostic (“IVD”) solution provider in China and engages in the production and sales of diagnostic reagents and instruments, and the provision of testing and research services. The Company’s headquarter is located at Changsha, Hunan Province, China and has two manufacturing bases and research and development (R&D) centers i

Status
Closed
Sector
Water Supply and Storage, Hospital, Commercial, Manufacturing (Industrial), Government
Location
China
Updated
22 Jul 2026
Source
International Finance Corporation (IFC)

ConstructChat

Ask ConstructChat about Sansure Biotech

Pick a question to edit it, or write your own.

First answer free · no account

I am a

Project Information FAQ

Project Information

4 Q
The project “Sansure Biotech” is an infrastructure initiative in the Water Supply and Storage sector, located in China. Taiyo aggregates data on it from International Finance Corporation (IFC).

Participants

Sponsoring Agency

Status

Original status

completed

Taiyo status

Closed

Taiyo last update

2026-07-22

Contact

Not available for this record.

Description

Description

Sansure Biotech Inc. (“Sansure Biotech” or the “Company”) is an in vitro diagnostic (“IVD”) solution provider in China and engages in the production and sales of diagnostic reagents and instruments, and the provision of testing and research services. The Company’s headquarter is located at Changsha, Hunan Province, China and has two manufacturing bases and research and development (R&D) centers in Changsha and Shanghai as well as three clinical laboratories in Changsha, Beijing and Shanghai. The Company has partnered with over 2,000 hospitals and laboratories in China, and its technology has been deployed in over 160 countries. IFC is proposing a US$55 million A loan to Sansure Biotech to improve the Company’s export capacities through: i) construction of an automated manufacturing and R&D facility in Changsha; ii) expansion in Indonesia and Philippines to establish subsidiaries that will be responsible for sales, marketing, product development and technology support in the Southeast Asia region; and iii) setting up representative offices in Africa.  The project in Changsha will be developed in two phases. The first phase includes the construction of reagent production building expected to be completed by the end of 2022. The second phase of the project includes an instrument production building, and a staff dormitory building, that is planned to be completed by the end of 2024.  All the Company’s laboratories and manufacturing facilities are located within industrial parks in China. The first phase of production localization under this project in Indonesia and Philippines will be started with leasing production facility and purchase of equipment locally through voluntary market transaction.The Company is engaging with the Africa Medical Equipment Facility (AMEF) platform to leverage AMEF’s resources and financing solution provided for local healthcare small and medium-sized enterprises (SMEs).

Original sector

other

Location

Country

China

Source

Source

International Finance Corporation (IFC)

URL

More Details

Record type

Project

Sector

Water Supply and Storage, Hospital, Commercial, Manufacturing (Industrial), Government

Article published date

2026-01-18

More on this project

Research

Free account

View all details

You are reading the public part. A free account opens the rest:

  • Every detail on this project
  • News and media coverage
  • Technical research
View all details

Free account · no card · lands you back on this project